Calithera Biosciences Inc. (CALA) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-12
12:02 pm
Purchase
2009-02-2813GCalithera Biosciences, Inc.
CALA
PRIMECAP MANAGEMENT CO/CA/512,675
14.530%
9,600increase
(+1.91%)
Filing
History
2021-02-11
5:25 pm
Sale
2020-12-3113GCalithera Biosciences, Inc.
CALA
BIOTECHNOLOGY VALUE FUND L P218,062
6.200%
-136,470decrease
(-38.49%)
Filing
History
2021-02-10
10:39 am
Purchase
2020-12-3113GCalithera Biosciences, Inc.
CALA
The Vanguard Group183,735
5.210%
183,735increase
(New Position)
Filing
History
2021-01-28
5:55 pm
Purchase
2020-12-3113GCalithera Biosciences, Inc.
CALA
BlackRock Inc.
BLK
283,420
8.000%
78,045increase
(+38.00%)
Filing
History
2021-01-25
4:06 pm
Purchase
2021-01-1313GCalithera Biosciences, Inc.
CALA
ADAGE CAPITAL PARTNERS GP L.L.C.200,000
5.670%
125,000increase
(+166.67%)
Filing
History
Goto Prev, 0, 1